FDA Panel Urges More Testing for Diabetes Drugs
Advisers to the Food and Drug Administration voted 14-2 on Wednesday that all new diabetes drugs should undergo longer studies to assure they don’t increase risks of heart problems. The agency currently doesn’t screen for heart risks …
More: continued here